Thinking skills may suffer on hot days

(Reuters Health) - Heat waves can sap productivity by slowing down thinking, even in the young and healthy, a small study suggests.

Babies who started solids slept better: study

(Reuters Health) - Babies who start on solids at three months sleep better than infants exclusively breastfed until six months of age, according to a new analysis of clinical trial data.

Sun-sensitive people need more than sunscreen to avoid sunburn

(Reuters Health) - People with pale skin who are sensitive to the sun should use several sun-protective behaviors to avoid sunburn, according to a new study.

Physician burnout a key driver of medical errors

(Reuters Health) - Burned-out doctors are more likely to make major medical errors, regardless of workplace safety measures, new research shows.

PTSD raises heart and stroke risk in World Trade Center cleanup crews

(Reuters Health) - More than 16 years after cleanup was completed at the site of the September 11, 2001 attack on New York City's World Trade Center complex, many who worked at the disaster site still struggle with post-traumatic stress disorder (PTSD) and may also have an elevated risk of heart attack and stroke as a result, researchers say.

Multivitamin-mineral supplements do not reduce heart disease, deaths

(Reuters Health) - Taking multivitamins and minerals does not reduce the risk of cardiovascular disease or associated deaths, according to a new review of existing research.

Israel’s Together to sell cosmetics based on cannabis, Dead Sea minerals

Israel's Together Pharma said on Tuesday it will set up a new company with Premier Dead Sea to sell cosmetics based on cannabis and Dead Sea minerals.

Israeli firm gets U.S. nod for advanced trials for non-opiate painkiller

Israeli pharmaceuticals company PainReform has received approval from the U.S. Food and Drug Administration (FDA) to begin late-stage clinical studies for a pain relief drug that is a departure from opiate-based narcotics, it said on Tuesday.

Hormone therapy poses stroke risk for transgender women

(Reuters Health) - Hormones given to people to align their sex with their gender pose a significant risk of serious blood clots and stroke among transgender women, one of the largest studies of transgender patients has concluded.

Trump slams Pfizer after July 1 drug price hikes

U.S. President Donald Trump on Monday took aim at Pfizer Inc and other U.S. drugmakers after they raised prices on some of their medicines on July 1, saying his administration would act in response.

Fewer older black patients survive long-term after cardiac arrest in the hospital

(Reuters Health) - After a cardiac arrest in the hospital, older black patients don't survive as long as older white patients, new data show.

Danone investigates Aptamil baby milk complaints

French food group Danone is investigating reports that its new Aptamil baby milk formula has made some infants unwell in Britain.

Team mix affects operating room social behavior

(Reuters Health) - Social behavior in the operating room is significantly affected by the mix of professional roles and the surgeon's gender, according to researchers who observed 200 surgical procedures.

CTI Biopharma’s cancer drug fails late-stage trial, shares tumble

CTI Biopharma Corp said on Monday its treatment for a type of blood cancer did not meet the main goal of a late-stage trial, sending its shares down 17 percent.

Insurers warn of rising premiums after Trump axes Obamacare payments again

Health insurers warned that a move by the Trump administration on Saturday to temporarily suspend a program that was set to pay out $10.4 billion to insurers for covering high-risk individuals last year could drive up premium costs and create marketplace uncertainty.

Cancer diagnosis tied to increased risk of diabetes

(Reuters Health) - People who get diagnosed with cancer may be more likely to develop diabetes, a Korean study suggests.

Biogen, Eisai’s Alzheimer’s drug succeeds in mid-stage trial, shares soar

Japanese drugmaker Eisai Co and Biogen Inc said that the final analysis of a mid-stage trial of their Alzheimer's drug showed positive results for patients who received the highest dose.

Explaining ‘herd immunity’ may convince more people to get flu shots

(Reuters Health) - The knowledge that getting a flu shot can help prevent flu from spreading in the community may help convince more people to get vaccinated, a U.S. study suggests.

Annoyance with wind turbines may affect quality of life

(Reuters Health) - People who can see wind turbines from their homes may be more annoyed by these machines and more likely to report quality of life issues than individuals who live further away from wind turbines, an industry-supported study suggests.

Mom’s healthy lifestyle lowers child’s risk of obesity

(Reuters Health) - Children whose mothers stick to healthy lifestyle practices are less likely to be obese than children of less healthy moms, researchers report.